 |
市場調查報告書
商品編碼
2077331
多囊性卵巢症候群診斷市場：按診斷測試類型、最終用戶和地區分類PCOS diagnostic Market, By Type of Diagnostic Test, By End-User, By Geography |
||||||
價格
簡介目錄
據估計，多囊性卵巢症候群（PCOS）診斷市場在2026年將達到41億美元，預計2033年將達到58.5億美元。預計從2026年到2033年，該市場將以5.2%的複合年成長率成長。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 41億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 5.20% | 2033年市場規模預測： | 58.5億美元 |
全球多囊性卵巢症候群（PCOS）診斷市場涵蓋荷爾蒙檢測、影像檢查、血液檢測及其他類似診斷檢測類別。這些檢測廣泛應用於醫院、診所、生育診所和居家醫療機構，並被各類終端用戶所採用。隨著各機構日益重視檢測的效能、效率和成本效益，這些領域的應用也穩定成長。
市場動態：
來自主要終端用戶產業的需求不斷成長、對更高效率和可靠性的需求以及持續的產品創新，預計將是推動全球多囊性卵巢症候群（PCOS）診斷市場成長的主要因素。醫院、診所和生育診所的廣泛應用進一步加速了這一成長勢頭。
例如，市場參與者正在實施專為醫院和診所應用場景設計的先進解決方案。此外，預計在預測期內，持續的技術進步和策略投資將為市場參與者創造新的成長機會。
本研究的主要特點：
- 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
- 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
- 本研究根據公司概況、產品系列、主要亮點、財務表現和策略等參數，介紹了全球 PCOS 診斷市場主要參與者的概況。
- 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
- 這份「全球多囊性卵巢症候群診斷市場」報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
- 相關人員可以透過利用全球多囊性卵巢症候群診斷市場分析中使用的各種策略矩陣來簡化決策過程。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章：市場動態、監管與趨勢分析
- 市場動態
- 促進因素
- 多囊性卵巢症候群盛行率增加
- 提高意識和早期診斷
- 診斷技術的進步
- 醫療保健支出增加
- 抑制因子
- 缺乏標準化的診斷標準
- 意識不足和診斷不足
- 成本低廉且價格實惠
- 機會
- 人們對卵巢症候群的治療認知不斷提高
- 促進因素
- 影響分析
- 主要亮點
- 監管趨勢
- 產品上市及核准
- PEST分析
- 波特五力分析
- 併購情景
第4章：多囊性卵巢症候群的診斷
- 供給面和需求面分析
- 經濟影響
第5章 多囊性卵巢症候群診斷市場：依診斷測試類型分類，2021-2033年
- 荷爾蒙測試
- 影像檢查
- 驗血
- 骨盆腔檢查
- 基因檢測
- 其他測試
第6章 多囊性卵巢症候群診斷市場：依最終用戶分類，2021-2033年
- 醫院和診所
- 不孕症治療診所
- 居家照護環境
- 診斷檢查室
第7章 多囊性卵巢症候群診斷市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
- 非洲
- 南非
- 北非
- 中非
第8章 競爭情勢
- Hoffmann-La Roche Ltd
- Abbott
- Quest Diagnostics
- Thermo Fisher Scientific Inc.
- Siemens Healthineers
- Bio-Rad Laboratories
- Hologic, Inc.
- Vitrolife
- Myriad Genetics, Inc.
- Ansh Labs
- Diagnostica Stago Inc.
- Beckman Coulter, Inc.
- Randox Laboratories Ltd.
- GE Healthcare
- PrivaPath Diagnostics
- Laboratory Corporation of America Holdings
- SRL Diagnostics
第9章
- 調查方法
- 關於本公司
簡介目錄
Product Code: CMI5850
Pcos Diagnostic Market is estimated to be valued at USD 4.10 Bn in 2026 and is expected to reach USD 5.85 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4.10 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.20% | 2033 Value Projection: | USD 5.85 Bn |
The global pcos diagnostic market includes offerings that span Hormone Test, Imaging Tests, and Blood Tests, and similar type of diagnostic test categories. These are applied across Hospitals & Clinics, Fertility Clinics, and Homecare Settings and adopted by diverse end users. As organizations increasingly prioritize performance, efficiency, and cost-effectiveness, adoption across these segments continues to grow steadily.
Market Dynamics:
Increasing demand from major end-use sectors, the need for improved efficiency and reliability, and ongoing product innovation are major factors expected to drive growth of the global pcos diagnostic market. Broader adoption across Hospitals & Clinics, and Fertility Clinics is reinforcing this momentum.
For instance, market players are introducing advanced solutions designed for Hospitals & Clinics use cases. Moreover, continued technological advancement and strategic investment are expected to create new growth opportunities for market players over the forecast period.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global pcos diagnostic market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Abbott, Quest Diagnostics, Thermo Fisher Scientific, Inc., Siemens Healthineers, Bio-Rad Laboratories, Hologic, Inc., Vitrolife, Myriad Genetics, Inc., Ansh Labs, Diagnostica Stago Inc., Beckman Coulter, Inc., Randox Laboratories Ltd., GE Healthcare, PrivaPath Diagnostics, Laboratory Corporation of America Holdings, and SRL Diagnostics, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global pcos diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pcos diagnostic market.
Detailed Segmentation:
- Global Pcos Diagnostic Market, By Type of Diagnostic Test (Revenue, USD Bn, 2021 - 2033)
- Hormone Test
- Imaging Tests
- Blood Tests
- Pelvic Examination
- Genetic Testing
- Other Tests
- Global Pcos Diagnostic Market, By End-User (Revenue, USD Bn, 2021 - 2033)
- Hospitals & Clinics
- Fertility Clinics
- Homecare Settings
- Diagnostic Laboratories
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- F. Hoffmann-La Roche Ltd*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Abbott
- Quest Diagnostics
- Thermo Fisher Scientific, Inc.
- Siemens Healthineers
- Bio-Rad Laboratories
- Hologic, Inc.
- Vitrolife
- Myriad Genetics, Inc.
- Ansh Labs
- Diagnostica Stago Inc.
- Beckman Coulter, Inc.
- Randox Laboratories Ltd.
- GE Healthcare
- PrivaPath Diagnostics
- Laboratory Corporation of America Holdings
- SRL Diagnostics
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market PCOS Diagnostic, By Type of Diagnostic Test
- Market PCOS Diagnostic, By End User
- Market PCOS Diagnostic, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Increasing Prevalence of PCOS
- Growing Awareness and Early Diagnosis
- Technological Advancements in Diagnostics
- Rising Healthcare Expenditure
- Restraints
- Lack of Standardized Diagnostic Criteria
- Limited Awareness and under diagnosis
- Cost and Affordability
- Opportunities
- Growing awareness about polycystic ovarian syndrome treatment
- Drivers
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER€(TM)s Analysis
- Merger and Acquisition Scenario
4. PCOS Diagnostic
- Supply Side and Demand Side Analysis
- Economic Impact
5. PCOS Diagnostic Market , By Type of Diagnostic Test, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Hormone Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Imaging Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Blood Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Pelvic Examination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Other Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
6. PCOS Diagnostic Market , By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€" 2033
- Segment Trends
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Fertility Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
7. PCOS Diagnostic Market , By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022€"2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Quest Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Hologic, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Vitrolife
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Myriad Genetics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Ansh Labs
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Diagnostica Stago Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Beckman Coulter, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Randox Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- PrivaPath Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Laboratory Corporation of America Holdings
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- SRL Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
02-2729-4219
+886-2-2729-4219
排卵預測試劑盒市場：按產品類型、檢測生物標記、應用、最終用戶和分銷管道分類的全球市場預測，2026-2032年
排卵預測試劑盒市場 - 全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、地區和競爭格局分類，2021-2031年
不孕症藥物市場規模、佔有率和成長分析：按藥物類型、適應症、應用、通路和地區分類－2026-2033年產業預測
不孕症治療市場規模、佔有率、趨勢和預測：按藥物類別、給藥途徑、分銷管道、最終用戶和地區分類，2026-2034 年
不孕症藥物市場：依藥物類型、給藥途徑、性別、通路和地區分類。
全球不孕症治療市場規模、佔有率、趨勢和成長分析報告（2026-2034）卵巢症候群（PCOS）治療市場－全球產業規模、佔有率、趨勢、機會及預測（按手術、藥物、診斷、最終用戶、地區和競爭格局分類），2021-2031年PCOS 診斷市場 - 全球產業規模、佔有率、趨勢、機會和預測（按檢測類型、最終用戶、地區和競爭細分，2020-2030 年預測）
不孕症藥物市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測